BAVIS_1170X120_10-19-20

Hikma names Patrick Genestin to lead generics business development 

Print Friendly, PDF & Email

LONDON – Hikma Pharmaceuticals  (Hikma), the multinational pharmaceutical company, announces that Patrick Genestin has been appointed vice president, Business Development, Generics. Genestin brings to Hikma more than 25 years of experience in the pharmaceutical industry as a results-driven  executive with strong financial, business development and M&A experience. He will be based at the company’s U.S.  headquarters in Berkeley Heights, NJ.

In this role,  Genestin is responsible for driving pipeline strategy and identifying new growth opportunities for  Hikma’s Generics business, including leading the execution of licensing and M&A deals, proactively identifying  business development opportunities and maintaining and growing Hikma’s contract manufacturing (CMO)  business.

“Patrick is an established business development leader whose extensive industry experience will be critical to  Hikma as we build on our successful track record,” said Brian Hoffmann, President, Hikma Generics. “His expertise  will be instrumental in helping us to develop new partnerships and acquire new products that will bolster our  differentiated pipeline. He will also work to leverage our state-of-the-art Columbus, Ohio manufacturing facility by  identifying new contract manufacturing opportunities, and will explore new growth areas including commercializing our portfolio outside of the US.”

“I am excited to be joining Hikma at an important time for the company and the Generics business,” said Genestin. “With its strong manufacturing capabilities and outstanding facilities, excellent quality record, and proven  ability to commercialize, Hikma’s Generics business has long been seen as a partner of choice in the industry. I  look forward to working together with Hikma’s excellent team to build on this position of strength, lead our pipeline  strategy, help deliver continued growth and ensure that important generic medicines continue to be made available  to the patients who rely on them.”

Prior to joining Hikma, he served as Vice President, Business Development & Licensing and Mergers & Acquisitions for the US entity of Sandoz, Inc. A native of France, Mr. Genestin received his bachelor’s degree from  L’Ecole Superieure de Commerce de Nantes and holds an M.B.A. in Finance from Penn State University.

 

London, June 9, 2021 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that Patrick Genestin has been appointed Vice President, Business Development, Generics. Mr.  Genestin brings to Hikma more than 25 years of experience in the pharmaceutical industry as a results-driven  executive with strong financial, business development and M&A experience. He will be based at the company’s US  headquarters in Berkeley Heights, NJ.

In this role, Mr. Genestin is responsible for driving pipeline strategy and identifying new growth opportunities for  Hikma’s Generics business, including leading the execution of licensing and M&A deals, proactively identifying  business development opportunities and maintaining and growing Hikma’s contract manufacturing (CMO)  business.

“Patrick is an established business development leader whose extensive industry experience will be critical to  Hikma as we build on our successful track record,” said Brian Hoffmann, President, Hikma Generics. “His expertise  will be instrumental in helping us to develop new partnerships and acquire new products that will bolster our  differentiated pipeline. He will also work to leverage our state-of-the-art Columbus, Ohio manufacturing facility by  identifying new contract manufacturing opportunities, and will explore new growth areas including commercializing our portfolio outside of the US.”

“I am excited to be joining Hikma at an important time for the company and the Generics business,” said Mr.  Genestin. “With its strong manufacturing capabilities and outstanding facilities, excellent quality record, and proven  ability to commercialize, Hikma’s Generics business has long been seen as a partner of choice in the industry. I  look forward to working together with Hikma’s excellent team to build on this position of strength, lead our pipeline  strategy, help deliver continued growth and ensure that important generic medicines continue to be made available  to the patients who rely on them.”

Prior to joining Hikma, Mr. Genestin served as Vice President, Business Development & Licensing and Mergers & Acquisitions for the US entity of Sandoz, Inc. A native of France, Mr. Genestin received his bachelor’s degree from  L’Ecole Superieure de Commerce de Nantes and holds an M.B.A. in Finance from Penn State University.


EMC_728x90


Comments are closed.